YOU ARE HERE >
MONEYCONTROL >
MARKETS >
Pharmaceuticals
> Profit & Loss account - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
LIVE
BSE
Oct 23, 11:05
2811.35
-1 (-0.04%)VOLUME 4,799
LIVE
NSE
Oct 23, 11:06
2812.50
1.75 (0.06%) VOLUME 326,800
- Quote
- CHARTS
- NEWS
- COMMENTS
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Track Dr%20Reddys%20Labs on the go with the moneycontrol app
Profit & Loss account of Dr Reddys Laboratories |
------------------- in Rs. Cr. ------------------- |
| Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | ||||||
 |
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| INCOME | ||||||||||
| Revenue From Operations [Gross] | 10,572.90 | 9,302.60 | 9,628.10 | 10,234.80 | 10,010.40 | |||||
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 84.20 | 82.90 | |||||
| Revenue From Operations [Net] | 10,572.90 | 9,302.60 | 9,628.10 | 10,150.60 | 9,927.50 | |||||
| Other Operating Revenues | 52.60 | 56.70 | 91.70 | 57.10 | 83.50 | |||||
| Total Operating Revenues | 10,625.50 | 9,359.30 | 9,719.80 | 10,207.70 | 10,011.00 | |||||
| Other Income | 238.40 | 204.00 | 591.20 | 244.80 | 222.80 | |||||
| Total Revenue | 10,863.90 | 9,563.30 | 10,311.00 | 10,452.50 | 10,233.80 | |||||
| EXPENSES | ||||||||||
| Cost Of Materials Consumed | 2,103.20 | 2,011.00 | 1,904.60 | 1,988.50 | 2,248.40 | |||||
| Purchase Of Stock-In Trade | 868.60 | 671.60 | 671.50 | 610.40 | 526.10 | |||||
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 94.20 | 92.40 | |||||
| Changes In Inventories Of FG,WIP And Stock-In Trade | 66.00 | -51.60 | 1.90 | -28.80 | -28.90 | |||||
| Employee Benefit Expenses | 1,931.90 | 1,843.00 | 1,803.30 | 1,710.00 | 1,490.90 | |||||
| Finance Costs | 56.80 | 62.80 | 57.20 | 63.80 | 63.80 | |||||
| Depreciation And Amortisation Expenses | 780.60 | 774.10 | 735.10 | 649.10 | 490.20 | |||||
| Other Expenses | 3,356.10 | 3,555.40 | 3,592.90 | 3,429.40 | 3,291.00 | |||||
| Total Expenses | 9,163.20 | 8,866.30 | 8,766.50 | 8,516.60 | 8,173.90 | |||||
| Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,700.70 | 697.00 | 1,544.50 | 1,935.90 | 2,059.90 | |||||
| Exceptional Items | 0.00 | 0.00 | 0.00 | -355.90 | 0.00 | |||||
| Profit/Loss Before Tax | 1,700.70 | 697.00 | 1,544.50 | 1,580.00 | 2,059.90 | |||||
| Tax Expenses-Continued Operations | ||||||||||
| Current Tax | 281.80 | 138.10 | 182.60 | 416.00 | 376.70 | |||||
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 97.00 | 0.00 | |||||
| Deferred Tax | 141.60 | -8.00 | -22.20 | -93.50 | 3.80 | |||||
| Total Tax Expenses | 423.40 | 130.10 | 160.40 | 225.50 | 380.50 | |||||
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1,277.30 | 566.90 | 1,384.10 | 1,354.50 | 1,679.40 | |||||
| Profit/Loss From Continuing Operations | 1,277.30 | 566.90 | 1,384.10 | 1,354.50 | 1,679.40 | |||||
| Profit/Loss For The Period | 1,277.30 | 566.90 | 1,384.10 | 1,354.50 | 1,679.40 | |||||
| Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| OTHER ADDITIONAL INFORMATION | ||||||||||
| EARNINGS PER SHARE | ||||||||||
| Basic EPS (Rs.) | 76.98 | 34.19 | 83.05 | 79.42 | 99.00 | |||||
| Diluted EPS (Rs.) | 76.85 | 34.12 | 82.88 | 79.14 | 98.00 | |||||
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS | ||||||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 766.80 | 867.70 | |||||
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 1,221.70 | 1,380.70 | |||||
| STORES, SPARES AND LOOSE TOOLS | ||||||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 107.00 | 81.10 | |||||
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 322.10 | 294.40 | |||||
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||||||
| Equity Share Dividend | 332.00 | 399.20 | 335.30 | 340.50 | 340.80 | |||||
| Tax On Dividend | 68.20 | 0.00 | 0.00 | 69.30 | 69.40 | |||||
| Equity Dividend Rate (%) | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 | |||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| ||||||||||
Results of Dr Reddys Labs
- News
- Results
- Estimates
- Analysis
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
No news.
Quick Links for drreddyslaboratories
Related Searches
drreddyslaboratories Stock Price, Dr%20Reddys%20Labs Stock Quote, Dr%20Reddys%20Labs Results , Dr%20Reddys%20Labs News ..
More »
Follow moneycontrol
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds |
Budget 2019 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Bangalore | Online Shopping in India | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore
| Clear Study Doubts | Education Franchisee Opportunity | Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Policy | Terms & Conditions | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.